bioAffinity Technologies (BIAF) Enterprise Value (2022 - 2025)
Historic Enterprise Value for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$7.7 million.
- bioAffinity Technologies' Enterprise Value fell 86250.0% to -$7.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.7 million, marking a year-over-year decrease of 86250.0%. This contributed to the annual value of -$1.1 million for FY2024, which is 6082.71% up from last year.
- As of Q3 2025, bioAffinity Technologies' Enterprise Value stood at -$7.7 million, which was down 86250.0% from -$802835.0 recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' Enterprise Value ranged from a high of -$444706.0 in Q1 2025 and a low of -$13.5 million during Q3 2022
- Moreover, its 4-year median value for Enterprise Value was -$2.8 million (2023), whereas its average is -$5.0 million.
- In the last 5 years, bioAffinity Technologies' Enterprise Value skyrocketed by 9034.57% in 2024 and then plummeted by 86250.0% in 2025.
- Quarter analysis of 4 years shows bioAffinity Technologies' Enterprise Value stood at -$11.4 million in 2022, then surged by 75.28% to -$2.8 million in 2023, then soared by 60.83% to -$1.1 million in 2024, then crashed by 596.65% to -$7.7 million in 2025.
- Its Enterprise Value was -$7.7 million in Q3 2025, compared to -$802835.0 in Q2 2025 and -$444706.0 in Q1 2025.